# Hair loss on a GLP-1: why it happens and when it stops

Updated 24 August 2026 · Written by the Penwise team

Hair shedding a few months into treatment is one of the more distressing things people encounter on these drugs, partly because it arrives without warning and partly because it is easy to read as permanent. In almost all cases it is telogen effluvium, a well-described response to rapid weight loss rather than a direct effect of the medication, and it has a characteristic and self-limiting timeline.

## What telogen effluvium is

Hair grows in cycles. At any moment most follicles are in the growth phase and a minority are in the resting phase, after which the hair sheds and the follicle starts again. A significant physiological stress can push an unusually large number of follicles into the resting phase at once.

The shedding then happens when that resting phase ends, which is why the timing is so counterintuitive: the hair falls out **two to four months after** the event that caused it, not during it. People routinely conclude that the shedding started for no reason, because by then the rapid weight loss that triggered it feels like old news.

- **2 to 4 months**: Typical delay between the trigger and the shedding starting
- **3 to 6 months**: Typical duration of the shedding phase
- **6 to 12 months**: Typical time for density to visibly recover afterwards

The hair usually comes back. Telogen effluvium is a shedding of hairs that were going to cycle anyway, in a synchronised burst, not a destruction of follicles. Regrowth is slow enough to be frustrating, and new growth often appears first as short baby hairs around the hairline.

## Why weight loss triggers it

Hair follicles are among the fastest-dividing tissues in the body and correspondingly sensitive to a resource shortfall. The trigger here is not the drug molecule, it is the rapid and substantial energy deficit the drug enables. The same shedding is well documented after bariatric surgery, crash dieting, serious illness, childbirth and major surgery.

Two things follow from that, and they are the useful part of understanding the mechanism:

- **Faster loss makes it more likely.** The rate of loss matters more than the total, which is one of the few practical levers there is.
- **Nutritional adequacy matters within that deficit.** Very low protein intake, and low iron, zinc or vitamin D, are all associated with hair shedding independently, and all of them are easy to fall into when appetite suppression cuts total intake sharply.

> Reported rates of hair loss in the major trials were low, in the low single digits of percent, and the pattern was consistent with weight-loss-related shedding rather than a drug toxicity. That does not make it less unpleasant when it happens to you.

## What actually influences it

There is no intervention that reliably stops telogen effluvium once it has started, because the follicles concerned entered the resting phase months ago. What can be influenced is the size of any further wave and the quality of the regrowth.

1. **Protein intake.** The single most common shortfall on these drugs, and one that matters for hair, muscle and recovery alike. The [muscle and protein page](https://penwiseapp.com/en/guides/muscle-loss-on-glp-1) covers how to get it in on a much smaller appetite.
2. **Ask about iron, ferritin, zinc, vitamin D and thyroid function.** Low ferritin in particular is a common and treatable contributor, and thyroid disease produces hair loss of its own and is worth excluding rather than assuming.
3. **The rate of loss.** If shedding is significant and loss is very fast, that is a legitimate thing to raise at a review. Slowing the descent is a real option, and it is a prescriber decision.
4. **Time.** Unsatisfying and true. The shedding phase runs its course and then stops.
5. **Be gentle with what is there.** Tight styles, heat and aggressive brushing do not cause telogen effluvium but they add avoidable breakage to a head of hair that is already thinner.

## When it is not telogen effluvium

The pattern above is specific, and things that do not match it deserve a proper assessment rather than being filed under expected side effects.

- **Patchy, defined bald spots**: Telogen effluvium is diffuse thinning across the whole scalp, not discrete circular patches. Patches suggest a different diagnosis, such as alopecia areata, and should be seen.
- **Scalp pain, scaling, redness or itching**: Shedding with an inflamed or symptomatic scalp is not the usual picture and needs a look, since scarring alopecias are treatable early and not later.
- **Shedding that runs beyond a year**: Chronic telogen effluvium exists, but a shedding phase that does not settle should prompt bloods and a diagnosis rather than continued waiting.
- **A receding hairline or crown thinning**: Pattern hair loss is a different process with different treatments. Weight loss can unmask it or make it more noticeable, and it does not resolve on its own the way effluvium does.

This page describes a common and well-documented pattern; it is not a diagnosis. Anything that does not fit is worth a professional opinion.

## What to track

This is one of the clearest cases where a record answers a question that memory cannot.

- When the shedding started, as a date. Everything about interpreting it depends on the interval from the trigger.
- Your rate of weight loss in the two to four months before it started. That is the window that caused it, not the current one.
- Your dose history, so you can see whether it followed a particular step up.
- Any bloods you have had done, and when, so a repeat is comparable.
- When the shedding slowed. It is the fact you will want at the next review, and nobody remembers it accurately.

Penwise records symptoms and notes against dates and doses, so the two-to-four-month lag that makes this confusing becomes something you can simply look at. The [side effects timeline](https://penwiseapp.com/en/guides/glp-1-side-effects-timeline) covers what lands when across the whole course, and the [weight loss timeline](https://penwiseapp.com/en/guides/glp-1-weight-loss-timeline) covers the rate of loss itself.

**Match the effect to the month that caused it** Symptoms, doses and weight on one timeline, so a delayed effect is traceable. Free core tracker, no account.

## Common questions

**Does Ozempic or Mounjaro cause hair loss?**

The shedding people experience is almost always telogen effluvium triggered by rapid weight loss rather than a direct effect of the drug. The same pattern is well documented after bariatric surgery, crash dieting and other major physiological stresses. Reported rates in the major trials were in the low single digits of percent.

**When does hair loss start on a GLP-1?**

Typically two to four months after the rapid weight loss that triggered it, because the affected follicles enter a resting phase first and shed at the end of it. That delay is why the shedding so often seems to start for no reason.

**How long does GLP-1 hair loss last?**

The shedding phase usually runs three to six months, and visible density generally recovers over the following six to twelve months. Telogen effluvium sheds hairs that were going to cycle anyway, in a synchronised burst, rather than destroying follicles.

**Will my hair grow back after stopping or after the weight loss slows?**

In the great majority of cases yes, because the follicles are not damaged. Regrowth is slow and often appears first as short new hairs around the hairline. Shedding that continues beyond a year, or that comes in defined patches, needs a proper assessment rather than more waiting.

**Can anything stop the shedding once it starts?**

Not reliably, because the follicles involved entered their resting phase months earlier. What can be influenced is any further wave and the quality of regrowth: adequate protein, checking iron and ferritin, zinc, vitamin D and thyroid function, and discussing the rate of weight loss with your prescriber.

**Does taking more protein help with hair loss on these drugs?**

Adequate protein matters, and inadequate protein is a common contributor because appetite suppression cuts total intake sharply. Going far above the recommended range has no established benefit for hair and displaces other food from an already small intake.

## Sources

Every factual claim on this page traces to the product information a regulator publishes, or to a published trial. Links open on the site of whoever issued the document.

- [Telogen Effluvium](https://www.ncbi.nlm.nih.gov/books/NBK430848/), StatPearls, NCBI Bookshelf
- [Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)](https://doi.org/10.1056/NEJMoa2032183), New England Journal of Medicine, 2021
- [Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)](https://doi.org/10.1056/NEJMoa2206038), New England Journal of Medicine, 2022

Penwise is a tracking and education tool, not a medical device. Nothing on this page is medical advice, a diagnosis or a recommendation to start, stop or change a dose. Dosing decisions belong to you and your clinician. Ozempic, Wegovy, Rybelsus, Saxenda and Victoza are trademarks of Novo Nordisk; Mounjaro, Zepbound and Trulicity are trademarks of Eli Lilly. Penwise is not affiliated with, endorsed by or connected to either company.

## Keep reading

- [Muscle loss on a GLP-1, and what to do about it](https://penwiseapp.com/en/guides/muscle-loss-on-glp-1): Every kilogram lost contains some lean mass. What proportion, why it matters more in year two than year one, and the two things that change the ratio.
- [GLP-1 weight loss timeline: what happens month by month](https://penwiseapp.com/en/guides/glp-1-weight-loss-timeline): Month one is titration, not results. What the trials actually recorded at each stage, why the first six weeks mislead everybody, and how to read your own curve.
- [The GLP-1 side effect timeline: what lands when](https://penwiseapp.com/en/guides/glp-1-side-effects-timeline): Nausea, fatigue, constipation and reflux do not arrive at random. Here is where they usually sit in the week, in the ladder and in the treatment.
- [Ozempic face: what it is and what actually causes it](https://penwiseapp.com/en/guides/ozempic-face): Not a drug effect on the face. Fat loss reaches the face like everywhere else, and it shows more there because of how facial fat is built.